Cargando…

Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study

Detalles Bibliográficos
Autores principales: Mignani, Renzo, Pieruzzi, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715373/
https://www.ncbi.nlm.nih.gov/pubmed/35004179
http://dx.doi.org/10.1016/j.ymgmr.2021.100838
_version_ 1784624115806633984
author Mignani, Renzo
Pieruzzi, Federico
author_facet Mignani, Renzo
Pieruzzi, Federico
author_sort Mignani, Renzo
collection PubMed
description
format Online
Article
Text
id pubmed-8715373
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87153732022-01-06 Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study Mignani, Renzo Pieruzzi, Federico Mol Genet Metab Rep Correspondence Elsevier 2021-12-23 /pmc/articles/PMC8715373/ /pubmed/35004179 http://dx.doi.org/10.1016/j.ymgmr.2021.100838 Text en © 2021 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Mignani, Renzo
Pieruzzi, Federico
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study
title Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study
title_full Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study
title_fullStr Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study
title_full_unstemmed Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study
title_short Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study
title_sort safety of a protocol for reduction of agalsidase beta infusion time in fabry disease: an italian multi-centre study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715373/
https://www.ncbi.nlm.nih.gov/pubmed/35004179
http://dx.doi.org/10.1016/j.ymgmr.2021.100838
work_keys_str_mv AT mignanirenzo safetyofaprotocolforreductionofagalsidasebetainfusiontimeinfabrydiseaseanitalianmulticentrestudy
AT pieruzzifederico safetyofaprotocolforreductionofagalsidasebetainfusiontimeinfabrydiseaseanitalianmulticentrestudy